hydroxyindoleacetic acid has been researched along with Smith-Lemli-Opitz Syndrome in 1 studies
(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.
Smith-Lemli-Opitz Syndrome: An autosomal recessive disorder of CHOLESTEROL metabolism. It is caused by a deficiency of 7-dehydrocholesterol reductase, the enzyme that converts 7-dehydrocholesterol to cholesterol, leading to an abnormally low plasma cholesterol. This syndrome is characterized by multiple CONGENITAL ABNORMALITIES, growth deficiency, and INTELLECTUAL DISABILITY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sparks, SE | 1 |
| Wassif, CA | 1 |
| Goodwin, H | 1 |
| Conley, SK | 1 |
| Lanham, DC | 1 |
| Kratz, LE | 1 |
| Hyland, K | 1 |
| Gropman, A | 1 |
| Tierney, E | 1 |
| Porter, FD | 1 |
1 other study available for hydroxyindoleacetic acid and Smith-Lemli-Opitz Syndrome
| Article | Year |
|---|---|
Decreased cerebral spinal fluid neurotransmitter levels in Smith-Lemli-Opitz syndrome.
Topics: Adolescent; Child; Child, Preschool; Cholesterol; Cross-Over Studies; Female; Homovanillic Acid; Hum | 2014 |